As communicated in Exchange Notice 18/16, Mylan N.V has announced a combined cash and share offer to acquire all outstanding shares of Meda AB (Meda).
On August 2, 2016, Mylan announced that all conditions for completion of the Offer have been fulfilled. Accordingly, Mylan will request for a de-listing of the Meda share
NASDAQ Derivatives Markets will (1) set a new expiration day for options, forwards and futures contracts in Meda (MEDA) and (2) settle the contracts at Fair Value according to the attached file. The new Expiration date will be at latest three trading days prior to the delisting date of the Meda share. Information regarding the new Expiration date will be communicated in a separate Exchange Notice as soon as more information is available.
For further information please see the attached file.